Central Venous Catheter Market 2022-2028: Global Size, Share, Growth, Trends

Precision Business Insights published a research report on "Central Venous Catheter Market: By Product (Tunneled Catheters and Non-Tunneled Catheters), By Property (Antimicrobial Catheters and Non-Antimicrobial Catheters), By Design by (Single Lumen, Double Lumen, and Multiple Lumen), By Composition (Polyurethane, and Polycarbonate and Silicon), and by End-Users (Hospitals, Ambulatory Surgical Centers, Clinics and Others) - Global/Region/Country Forecast to 2028"

A central line and central venous line is another name for a central venous catheter. It is a flexible tube that is put into a vein beneath the right side of the collarbone and led to the superior vena cava, a big vein that leads to the heart. A central venous catheter is being used to administer various fluids, which can then be conveniently administered into the patients' bodies. Intravenous fluid, blood transfusions, and chemotherapeutic medicines are among the fluids. Over the projected period, the global central venous catheter market is expected to be constrained by the COVID-19 pandemic. For example, a study published in Current Oncology, a Canadian Cancer Research Journal, in June 2020 evaluated the impact of the COVID-19 epidemic in China on Stage II and Stage III colon cancer patients receiving adjuvant chemotherapy treatment.

View Detailed Report Description at https://precisionbusinessinsights.com/market-reports/central-venous-catheter-market/

The global central venous catheter market is expected to be driven by expanding acceptance and requirement for antimicrobial-coated catheters, rising number of diseases including cancer, end-stage renal disease, and others, aging population, and rising usage of tip location devices. Other drivers that are likely to propel the global central venous catheter market include advantageous insurance and reimbursement regulations, technical innovation, and early acceptance of diagnostic methods. National cancer treatment expenditures in the United States were almost USD 120 billion in 2010, according to the US Department of Health and Human Services, and are expected to reach USD 155 billion by 2020. Furthermore, the hazards connected with catheters and pricing pressure are expected to stymie the worldwide central venous catheter market's growth. However, dangers associated with catheters, such as central vein injury, pulmonary problems, cardiac complications, device malfunction, and catheter-related bloodstream infection, are projected to limit worldwide market growth throughout the forecast period.

Furthermore, the high price of antimicrobial coated catheters is likely to stifle the target market's expansion throughout the forecast period.
The central venous catheter market has been fragmented on the basis of route of insertion, product type, application, end-user and region. On the basis of product type, the market can be divided into peripherally-inserted central catheter (PICC), tunneled catheter, non-tunneled catheters, and implanted port. On the basis of route of insertion, the central venous catheter market can be bifurcated into subcutaneous and intravenous. On the basis of application, the central venous catheter market can be classified into administration of fluid and nutrition, medication administration, transfusion of blood products, and diagnostic testing. In terms of end-user, the market can be segmented into clinics, hospitals, ambulatory surgery centers, and diagnostic centers.

Owing to the increased healthcare infrastructure and simple availability of catheters in healthcare facilities, North America is likely to lead the global market. Furthermore, cancer is becoming more prevalent in numerous countries throughout the region. Due to an increase in the number of patients having dialysis and blood transfusions across the area, Europe is predicted to be the second largest producer for central venous catheters. Over the projection period, the market in Asia Pacific is predicted to develop at a faster rate due to an expanding patient pool, rising government initiatives to improve healthcare facilities, and increasing disposable income in various countries in the area.

Request sample report at https://precisionbusinessinsights.com/request-sample?product_id=36802

There are several industry players working in the Central Venous Catheter Market, which include Abbott Laboratories (U.S.) Hoffmann-La Roche Ltd. (Switzerland), AbbVie Inc. (U.S.) Arquer Diagnostics Ltd. (U.K.) Illumina, Inc. (U.S.) Qiagen (Germany)

Contact:
Mr. Satya
Precision Business InsightsTM | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 - 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

This release was published on openPR.